THE APPROVAL OF VEDOLIZUMAB FOR THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN BRAZIL: the beginning of a new biological era

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics